<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical features and diagnosis of allergic contact dermatitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical features and diagnosis of allergic contact dermatitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical features and diagnosis of allergic contact dermatitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph Fowler, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeffrey Callen, MD, FACP, FAAD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H27385235"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Allergic contact dermatitis (ACD) is the classic presentation of a T cell-mediated, delayed-type hypersensitivity response to exogenous agents [<a href="#rid1">1,2</a>]. The words "dermatitis" and "eczema" are often used interchangeably to describe a pattern of inflammation of the skin characterized acutely by erythema, vesiculation, and pruritus  (<a class="graphic graphic_picture graphicRef74631" href="/d/graphic/74631.html" rel="external">picture 1</a>). Chronic exposure typically leads to reduction of the erythema accompanied by lichenification (thickening and hardening of the skin) and persistence of itch  (<a class="graphic graphic_picture graphicRef69623" href="/d/graphic/69623.html" rel="external">picture 2</a>). The clinical presentation may vary depending upon the triggering agent and individual's reactivity, but in most cases, the lesions are primarily confined to the site of contact [<a href="#rid3">3,4</a>].</p><p>This topic will discuss the clinical presentation, diagnosis, and differential diagnosis of ACD. The pathophysiology, patch testing for, and management of ACD are discussed separately. Eyelid contact dermatitis is also reviewed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13653.html" rel="external">"Basic mechanisms and pathophysiology of allergic contact dermatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16691.html" rel="external">"Patch testing"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/120320.html" rel="external">"Eyelid dermatitis (eczema)"</a>.)</p><p></p><p class="headingAnchor" id="H27385242"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>The incidence and prevalence of ACD in the general population are not known. Data are often extrapolated from surveillance studies on occupational dermatitis. In industrialized nations, up to 30 percent of all occupational diseases involve the skin. Irritant and contact dermatitis account for more than 90 percent of cases of occupational skin disease [<a href="#rid5">5</a>].</p><p>Surveillance studies in the United States and United Kingdom have reported an annual incidence of contact dermatitis (including irritant and ACD) of 13 to 34 cases per 100,000 workers [<a href="#rid6">6-8</a>]. The agents most frequently implicated in occupational contact dermatitis included rubber-related materials, protective equipment, soap and cleansers, resins, and acrylics.</p><p>Information on the main allergens responsible for ACD in the general population is derived from retrospective studies of patch testing referral centers [<a href="#rid9">9</a>]. In one study, metals, fragrances, topical antibiotics, preservatives, chemicals used in hair care products, topical corticosteroids, glues, plastics, and rubber were the most common allergen groups associated with positive patch test reaction [<a href="#rid10">10</a>].</p><p>In a meta-analysis of 28 studies including over 20,000 patch-tested individuals from the general population, the pooled prevalence of contact allergy was 20.1 percent (95% CI 16.8-23.7), with nickel being the most common allergen, followed by fragrance mix, cobalt, and <em>Myroxylon pereirae</em> [<a href="#rid11">11</a>]. Among children, nickel sulfate, ammonium persulfate, gold <a class="drug drug_general" data-topicid="9939" href="/d/drug information/9939.html" rel="external">sodium thiosulfate</a>, thimerosal, and toluene-2,5-diamine (p-toluenediamine) are the most common sensitizers [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/13656.html" rel="external">"Common allergens in allergic contact dermatitis"</a>.)</p><p>Multiple studies from around the world indicate that, of patients presenting for patch testing, 20 to up to 40 percent will be allergic to nickel [<a href="#rid13">13-18</a>]. In North America, the most common cause of ACD is from contact with poison ivy, oak, and sumac. (See  <a class="medical medical_review" href="/d/html/1728.html" rel="external">"Poison ivy (<i>Toxicodendron</i>) dermatitis"</a>.)</p><p>Risk factors for ACD include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupation</strong> –<strong> </strong>Workers at highest risk of ACD include health professionals, chemical industry workers, beauticians and hairdressers, machinists, and construction workers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> –<strong> </strong>ACD was once considered a disorder of the adult population. Children were thought to be spared because of a low exposure to potential allergens and an immature immune system. However, it is now recognized that contact sensitization begins in early childhood via exposures such as vaccinations, piercing, topical medications, and cosmetics [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent1">The incidence of ACD increases with age. Repetitive and prolonged exposure to potential sensitizers may account for the high rate of ACD in older adults. Medical comorbidities, including stasis dermatitis and venous ulcerations, are contributing factors [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/d/html/13670.html" rel="external">"Stasis dermatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History of atopic dermatitis</strong> –<strong> </strong>The role of atopy in ACD is controversial, although several studies report a high rate (up to over 50 percent) of positive patch tests among atopic individuals [<a href="#rid22">22-28</a>]. However, a 2017 meta-analysis of 74 studies did not find a difference in the frequency of contact sensitization between individuals with atopic dermatitis and those without (odds ratio [OR] 0.89, 95% CI 0.77-1.03) [<a href="#rid29">29</a>].</p><p></p><p class="headingAnchor" id="H27385267"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H27385276"><span class="h2">Lesion morphology</span><span class="headingEndMark"> — </span>Acute ACD lesions consist of erythematous, indurated, scaly plaques  (<a class="graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220" href="/d/graphic/51066.html" rel="external">picture 3A-C</a>). Vesiculation and bullae may be seen in severe cases  (<a class="graphic graphic_picture graphicRef74631" href="/d/graphic/74631.html" rel="external">picture 1</a>). Edema may be prominent in areas in which the skin is thin, such as the eyelids, lips, and genitalia  (<a class="graphic graphic_picture graphicRef72864" href="/d/graphic/72864.html" rel="external">picture 4</a>).</p><p>Repeated or continued exposure to allergens results in chronic disease. The skin becomes dry, scaly, and thicker as a result of acanthosis, hyperkeratosis, edema, and cellular infiltration in the dermis  (<a class="graphic graphic_picture graphicRef69623" href="/d/graphic/69623.html" rel="external">picture 2</a>). Lichenification and fissuring may develop later [<a href="#rid30">30</a>]. Secondary changes include excoriation or impetiginization  (<a class="graphic graphic_picture graphicRef73185" href="/d/graphic/73185.html" rel="external">picture 5</a>). Subacute dermatitis has a mixture of both acute and chronic features [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H8829787"><span class="h2">Lesion distribution</span><span class="headingEndMark"> — </span>ACD is typically localized to the skin areas that come in contact with the allergen  (<a class="graphic graphic_picture graphicRef77613 graphicRef70264 graphicRef60422" href="/d/graphic/77613.html" rel="external">picture 6A-C</a>). However, patchy or diffuse distributions may occur, depending upon the nature of the allergen or secondary transfer of the allergen from the primary site of contact to distant skin areas:</p><p class="bulletIndent1"><span class="glyph">●</span>The involvement of hands, face, or eyelids, which most commonly come in contact with the environment, occurs most frequently in ACD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Allergens applied to the scalp, including hair dyes and shampoos, may elicit dermatitis in adjacent skin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Facial lesions may result from direct contact with cosmetic products or tools or from involuntary transfer of allergens to the face (eg, eyelid ACD from nail polish).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pendant-like distribution of lesions (berloque dermatitis) in the neck and chest suggests a reaction to fragrances in perfumes and lotions  (<a class="graphic graphic_picture graphicRef81457 graphicRef68245" href="/d/graphic/81457.html" rel="external">picture 7A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A diffuse or patchy dermatitis of the trunk, often with accentuation in the axillary folds, may be caused by cloth dyes or textiles. Rubber components may induce ACD at the site of contact with elastic waistbands  (<a class="graphic graphic_picture graphicRef81309" href="/d/graphic/81309.html" rel="external">picture 8</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Periorificial ACD involving periocular, perioral, and genital areas may be induced by fragrances, detergents, or preservatives in hygiene products, including moist wipes [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermatitis involving the dorsal aspect of the foot suggests ACD related to shoe chemicals (eg, rubber accelerators or potassium dichromate)  (<a class="graphic graphic_picture graphicRef51220" href="/d/graphic/51220.html" rel="external">picture 3C</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Involvement of photoexposed areas suggests photoallergic contact dermatitis. (See  <a class="medical medical_review" href="/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Photoallergy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occupational ACD frequently involves the hands and requires a careful ascertainment of occupation-specific exposures.</p><p></p><p class="headingAnchor" id="H27385283"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>The dominant symptom of ACD is itch. However, ACD may cause a variety of other symptoms, including burning, stinging, or pain [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H3204593"><span class="h1">DISEASE COURSE</span><span class="headingEndMark"> — </span>If left untreated, ACD can evolve from an acute form to a subacute and then chronic eczematous dermatitis. Chronic dermatitis can negatively impact an individual's health-related quality of life, particularly in social functioning and psychologic wellbeing [<a href="#rid34">34,35</a>]. Successful allergen avoidance can result in clearance of ACD.</p><p>Persistence of dermatitis in the face of dutiful allergen avoidance suggests an alternative diagnosis (eg, systemic medication allergy, cutaneous lymphoma) or concurrent diagnosis (ie, atopic dermatitis). (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H27385290"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>The histology of ACD mirrors the clinical picture. In acute ACD, the epidermis is of normal thickness, and spongiosis (intercellular edema leading to the disruption of intercellular adhesion and formation of vesicles) is the dominant feature  (<a class="graphic graphic_picture graphicRef57868" href="/d/graphic/57868.html" rel="external">picture 9</a>). An additional feature is the exocytosis of lymphocytes and eosinophils into spongiotic foci. The upper dermis contains an infiltrate of lymphocytes, histiocytes, and eosinophils, with perivascular accentuation [<a href="#rid36">36</a>].</p><p>In subacute ACD, there are mild to moderate spongiosis, moderate acanthosis (epidermal hyperplasia from increased mitotic activity of keratinocytes), and a denser dermal lymphohistiocytic infiltrate. Chronic lesions may show prominent epidermal acanthosis with hyperkeratosis and areas of parakeratosis. Spongiosis may be present focally but often is minimal. The inflammatory infiltrate is sparse.</p><p class="headingAnchor" id="H1646554"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of ACD is based upon a combination of [<a href="#rid4">4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical features (morphology, location, and symptoms) of the eruption</p><p class="bulletIndent1"><span class="glyph">●</span>History of exposure to a putative allergen during work, hobbies, or home activities</p><p class="bulletIndent1"><span class="glyph">●</span>Patch testing results, if performed</p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory tests and/or histopathologic examination</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of recurrence after empirical treatment of the dermatitis and avoidance of the suspected allergen</p><p></p><p class="headingAnchor" id="H8451683"><span class="h2">Clues from clinical examination</span><span class="headingEndMark"> — </span>The morphology, regional distribution, and temporal course of dermatitis frequently suggest the diagnosis of ACD. (See <a class="local">'Lesion morphology'</a> above and <a class="local">'Lesion distribution'</a> above.)</p><p>The typical appearance of ACD is a well-demarcated, pruritic, eczematous eruption localized to the area of skin that comes in contact with the allergen  (<a class="graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220" href="/d/graphic/51066.html" rel="external">picture 3A-C</a>). The eruption may be acute, with vesiculation and weeping, or chronic (lichenified or scaly plaques).</p><p>The eruption may not remain anatomically limited to the initial site of contact. For example, a patient with a <a class="drug drug_general" data-topicid="9686" href="/d/drug information/9686.html" rel="external">neomycin</a> contact allergy may exhibit a modest eruption at the site of application on the torso and a diffuse, concomitant dermatitis of the face due to passive transfer of the allergenic ointment to the face. Body washes or shampoos or cloth dyes and textiles may cause a patchy or diffuse dermatitis.</p><p>Less commonly, ACD may present with a photosensitivity reaction: The eruption is limited to photo-exposed skin areas and follows the application of sunscreens, fragrances, or topical nonsteroidal anti-inflammatory drugs (NSAIDs)  (<a class="graphic graphic_picture graphicRef63557" href="/d/graphic/63557.html" rel="external">picture 10</a>). (See  <a class="medical medical_review" href="/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Photoallergy'</a>.)</p><p class="headingAnchor" id="H111504337"><span class="h2">History</span><span class="headingEndMark"> — </span>A comprehensive, multiyear history is helpful for the diagnosis of ACD  (<a class="graphic graphic_table graphicRef65321" href="/d/graphic/65321.html" rel="external">table 1</a>). The source of contact with allergens may be identified by reviewing the patient's activities, including occupation and hobbies. Products and objects for personal use, including prescription or over-the-counter topical preparations, cosmetics and toiletries, hair dyes, fragrances, eyeglasses, gloves, and clothing, should be reviewed. A patient's recall may not be complete, and revisiting the history after obtaining the results of patch testing may be useful.</p><p>A history of long-term exposure to an allergen does not rule out contact allergy, since multiple exposures are typically necessary for sensitization and dermatitis to occur. In addition, an individual's susceptibility to ACD may change over time because of aging, customs, or comorbidities (eg, stasis dermatitis and leg ulcers) [<a href="#rid31">31</a>]. Infrequently, sensitization may occur after a single exposure.</p><p>Health professionals, chemical industry workers, beauticians and hairdressers, machinists, and construction workers have an increased risk of developing occupational ACD [<a href="#rid37">37</a>]. However, exposure to common industrial allergens, including cements, glues, plasters, and solvents, may also occur at home.</p><p>A history of improvement during weekends or holidays suggests an occupational origin, whereas worsening during weekends or holidays suggests recreational exposure to allergens. A seasonal variation may indicate photo-aggravation or photoallergy [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Photoallergy'</a>.)</p><p>A previous history of contact dermatitis may provide a clue to the origin of a relapse. For example, earring dermatitis may precede nickel dermatitis of the hands by several years.</p><p>Patients with ACD often report a history of atopy (childhood flexural eczema, asthma, hay fever, or conjunctivitis).</p><p class="headingAnchor" id="H8451814"><span class="h2">Patch testing</span><span class="headingEndMark"> — </span>Patch testing is an essential investigation in patients with persistent eczematous eruptions when contact allergy is suspected or cannot be ruled out [<a href="#rid1">1,9,38</a>]. Patch testing may help to identify allergens that should be avoided and is discussed separately. (See  <a class="medical medical_review" href="/d/html/16691.html" rel="external">"Patch testing"</a>.)</p><p class="headingAnchor" id="H48321080"><span class="h2">Laboratory tests and biopsy</span><span class="headingEndMark"> — </span>Laboratory tests are not routinely necessary in the evaluation of patients for ACD but may be helpful in excluding other disorders with similar clinical features. For example, a KOH examination of scale from the eruption or swab cultures may rule out a fungal or bacterial infection [<a href="#rid31">31</a>].</p><p>Histologic examination on itself may provide little help in differentiating ACD from other eczematous dermatitides (including irritant contact dermatitis (ICD), atopic, nummular, dyshidrotic, and seborrheic dermatitis), since all present eosinophilic spongiosis as the key feature. However, histologic examination may be helpful when the diagnosis is not clear.</p><p class="headingAnchor" id="H1042995662"><span class="h2">Response to empiric therapy</span><span class="headingEndMark"> — </span>When the possible offending allergen is identified on the basis of clinical features and history, response to empiric therapy may avoid the need for patch testing. Improvement or resolution of the dermatitis with allergen avoidance and empiric treatment supports the diagnosis of ACD [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a>.)</p><p class="headingAnchor" id="H3204492"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H1646445"><span class="h2">Clinical</span><span class="headingEndMark"> — </span>ACD can mimic or complicate other types of eczema and other dermatoses as listed in the table  (<a class="graphic graphic_table graphicRef50914" href="/d/graphic/50914.html" rel="external">table 2</a> and <a class="graphic graphic_picture graphicRef63945 graphicRef55722 graphicRef60650" href="/d/graphic/63945.html" rel="external">picture 11A-C</a>) [<a href="#rid40">40</a>].</p><p>Differentiating ACD from irritant contact dermatitis (ICD) is particularly difficult since they have a similar clinical and histopathologic morphology [<a href="#rid41">41</a>]. Patch testing may be useful to confirm the diagnosis of ACD. There is no specific test for the diagnosis of ICD. (See  <a class="medical medical_review" href="/d/html/13661.html" rel="external">"Irritant contact dermatitis in adults"</a>.)</p><p class="headingAnchor" id="H10326699"><span class="h2">Histopathologic</span><span class="headingEndMark"> — </span>Eosinophilic spongiosis and exocytosis of eosinophils and lymphocytes are the key features of ACD and other eczematous dermatitides but may be seen also in other skin diseases.</p><p>For example, eosinophilic spongiosis may be the only histologic feature in the early, urticarial phase of bullous pemphigoid [<a href="#rid42">42</a>]. Direct immunofluorescence staining and measurement of circulating anti-BP antibodies will differentiate ACD from bullous pemphigoid.</p><p>Early, patch stage mycosis fungoides (MF) may be difficult to differentiate from subacute or chronic ACD. Both diseases show minimal or no spongiosis and lymphocytic exocytosis. However, in MF, lymphocytic exocytosis is more prominent, lymphocytes may have atypical features (hyperchromatic, cerebriform nuclei), and clusters of atypical lymphocytes (Pautrier microabscesses) may be seen in the epidermis  (<a class="graphic graphic_picture graphicRef61650" href="/d/graphic/61650.html" rel="external">picture 12</a>).</p><p class="headingAnchor" id="H1359774341"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113033.html" rel="external">"Society guideline links: Contact dermatitis"</a>.)</p><p class="headingAnchor" id="H48321072"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> –<strong> </strong>Allergic contact dermatitis (ACD) is a T cell-mediated, delayed-type hypersensitivity response to exogenous agents. Workers at highest risk of ACD include health professionals, chemical industry workers, beauticians and hairdressers, machinists, and construction workers. Contact allergens may be found at home or in the workplace and may include metals, glues, plastics, rubber, fragrances, topical antibiotics, preservatives, and chemicals used in hair care and cosmetic products. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> –<strong> </strong>Acute ACD lesions consist of pruritic, erythematous, indurated, scaly plaques, typically localized to the skin areas that come in contact with the allergen  (<a class="graphic graphic_picture graphicRef51066 graphicRef70989 graphicRef51220" href="/d/graphic/51066.html" rel="external">picture 3A-C</a>). Vesiculation and bullae may be seen in severe cases  (<a class="graphic graphic_picture graphicRef74631" href="/d/graphic/74631.html" rel="external">picture 1</a>). Edema of the eyelids, lips, and genitalia may be prominent  (<a class="graphic graphic_picture graphicRef72864" href="/d/graphic/72864.html" rel="external">picture 4</a>).</p><p></p><p class="bulletIndent1">In chronic ACD, the skin is dry, scaly, and thicker. Lesions are typically localized in the skin areas that come in contact with the allergen  (<a class="graphic graphic_picture graphicRef77613 graphicRef70264" href="/d/graphic/77613.html" rel="external">picture 6A-B</a>). (See <a class="local">'Lesion morphology'</a> above and <a class="local">'Lesion distribution'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> –<strong> </strong>The diagnosis of ACD is based on a combination of clinical features (ie, morphology and location of lesions, symptoms), history of exposure to a putative allergen, and patch testing results, if performed. The involvement of hands, feet, eyelids, and lips, which most commonly come in contact with the environment, suggest the diagnosis of ACD.</p><p></p><p class="bulletIndent1">The source of contact allergens can be identified through a detailed review of the patient's exposures at home and in the workplace  (<a class="graphic graphic_table graphicRef65321" href="/d/graphic/65321.html" rel="external">table 1</a>). Patch testing may be required to confirm the diagnosis and differentiate ACD from other types of eczematous dermatitis  (<a class="graphic graphic_table graphicRef50914" href="/d/graphic/50914.html" rel="external">table 2</a>). (See <a class="local">'Diagnosis'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H142019632"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges James Yiannias, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mowad CM, Anderson B, Scheinman P, et al. Allergic contact dermatitis: Patient diagnosis and evaluation. J Am Acad Dermatol 2016; 74:1029.</a></li><li class="breakAll">Gaspari AA. Pathogenesis of allergic contact hypersensitivity. In: Fisher's Contact Dermatitis, 7th ed, Fowler JF, Zirwas MJ (Eds), Contact Dermatitis Institute, 2019.</li><li><a class="nounderline abstract_t">Krasteva M, Kehren J, Sayag M, et al. Contact dermatitis II. Clinical aspects and diagnosis. Eur J Dermatol 1999; 9:144.</a></li><li><a class="nounderline abstract_t">Rashid RS, Shim TN. Contact dermatitis. BMJ 2016; 353:i3299.</a></li><li><a class="nounderline abstract_t">Clark SC, Zirwas MJ. Management of occupational dermatitis. Dermatol Clin 2009; 27:365.</a></li><li><a class="nounderline abstract_t">Meyer JD, Chen Y, Holt DL, et al. Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) 2000; 50:265.</a></li><li><a class="nounderline abstract_t">Turner S, Carder M, van Tongeren M, et al. The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol 2007; 157:713.</a></li><li class="breakAll">United States Department of Labor, Bureau of Labor Statistics. News release - Workplace Injuries and Illnesses - 2009. www.bls.gov/news.release/archives/osh_10212010.pdf (Accessed on August 22, 2011).</li><li><a class="nounderline abstract_t">Zawawi S, Yang YW, Cantwell HM, et al. Trends in Patch Testing With the Mayo Clinic Standard Series, 2017-2021. Dermatitis 2023; 34:405.</a></li><li><a class="nounderline abstract_t">Wentworth AB, Yiannias JA, Keeling JH, et al. Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). J Am Acad Dermatol 2014; 70:269.</a></li><li><a class="nounderline abstract_t">Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: A systematic review and meta-analysis. Contact Dermatitis 2019; 80:77.</a></li><li><a class="nounderline abstract_t">Bonitsis NG, Tatsioni A, Bassioukas K, Ioannidis JP. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis 2011; 64:245.</a></li><li><a class="nounderline abstract_t">Aguilar-Bernier M, Bernal-Ruiz AI, Rivas-Ruiz F, et al. [Contact sensitization to allergens in the Spanish standard series at Hospital Costa del Sol in Marbella, Spain: a retrospective study (2005-2010)]. Actas Dermosifiliogr 2012; 103:223.</a></li><li><a class="nounderline abstract_t">Zug KA, Warshaw EM, Fowler JF Jr, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis 2009; 20:149.</a></li><li><a class="nounderline abstract_t">Nonaka H, Nakada T, Iijima M, Maibach HI. Metal patch test results from 1990-2009. J Dermatol 2011; 38:267.</a></li><li><a class="nounderline abstract_t">Yin R, Huang XY, Zhou XF, Hao F. A retrospective study of patch tests in Chongqing, China from 2004 to 2009. Contact Dermatitis 2011; 65:28.</a></li><li><a class="nounderline abstract_t">Carøe C, Andersen KE, Mortz CG. Fluctuations in the prevalence of nickel and cobalt allergy in eczema patients patch tested after implementation of the nickel regulation in Denmark. Contact Dermatitis 2011; 64:126.</a></li><li><a class="nounderline abstract_t">Uter W, Rämsch C, Aberer W, et al. The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis 2009; 61:31.</a></li><li><a class="nounderline abstract_t">Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol 2010; 76:514.</a></li><li><a class="nounderline abstract_t">Simonsen AB, Deleuran M, Johansen JD, Sommerlund M. Contact allergy and allergic contact dermatitis in children - a review of current data. Contact Dermatitis 2011; 65:254.</a></li><li><a class="nounderline abstract_t">Prakash AV, Davis MD. Contact dermatitis in older adults: a review of the literature. Am J Clin Dermatol 2010; 11:373.</a></li><li><a class="nounderline abstract_t">de Groot AC. The frequency of contact allergy in atopic patients with dermatitis. Contact Dermatitis 1990; 22:273.</a></li><li><a class="nounderline abstract_t">Giordano-Labadie F, Rancé F, Pellegrin F, et al. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis 1999; 40:192.</a></li><li><a class="nounderline abstract_t">Czarnobilska E, Obtulowicz K, Dyga W, et al. Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema. Contact Dermatitis 2009; 60:264.</a></li><li><a class="nounderline abstract_t">Belhadjali H, Mohamed M, Youssef M, et al. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis 2008; 58:188.</a></li><li><a class="nounderline abstract_t">Thyssen JP, Linneberg A, Engkilde K, et al. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol 2012; 166:1255.</a></li><li><a class="nounderline abstract_t">Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol 2013; 69:232.</a></li><li><a class="nounderline abstract_t">Silverberg JI, Hou A, Warshaw EM, et al. Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016. J Allergy Clin Immunol Pract 2021; 9:2853.</a></li><li><a class="nounderline abstract_t">Hamann CR, Hamann D, Egeberg A, et al. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis. J Am Acad Dermatol 2017; 77:70.</a></li><li class="breakAll">Beck MH, Wilkinson SM. Contact dermatitis: Allergic. In: Rook's Textbook of Dermatology, 8th ed, Burns T, Breathnach S, Cox N, Griffiths C (Eds), Wiley-Blackwell, 2010. Vol II.</li><li class="breakAll">Cohen DE, Jacob SE. Allergic contact dermatitis. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw-Hill Professional, 2007.</li><li><a class="nounderline abstract_t">Gardner KH, Davis MD, Richardson DM, Pittelkow MR. The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone. Arch Dermatol 2010; 146:886.</a></li><li class="breakAll">Regional contact dermatitis. In: Fisher's Contact Dermatitis, 6th ed, Rietschel RL, Fowler JF Jr (Eds), BC Decker, 2008. p.66.</li><li><a class="nounderline abstract_t">Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41:151.</a></li><li><a class="nounderline abstract_t">Hutchings CV, Shum KW, Gawkrodger DJ. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 2001; 45:17.</a></li><li class="breakAll">Lever's Histopathology of the Skin, 10th ed, Elder DE, Elenitsas R, Johnson BL Jr, et al (Eds), Lippincott Williams &amp; Wilkins, 2009.</li><li><a class="nounderline abstract_t">Beltrani VS, Beltrani VP. Contact dermatitis. Ann Allergy Asthma Immunol 1997; 78:160.</a></li><li><a class="nounderline abstract_t">Bourke J, Coulson I, English J, British Association of Dermatologists. Guidelines for care of contact dermatitis. Br J Dermatol 2001; 145:877.</a></li><li><a class="nounderline abstract_t">Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician 2010; 82:249.</a></li><li><a class="nounderline abstract_t">Rietschel RL. Clues to an accurate diagnosis of contact dermatitis. Dermatol Ther 2004; 17:224.</a></li><li><a class="nounderline abstract_t">Ale IS, Maibacht HA. Diagnostic approach in allergic and irritant contact dermatitis. Expert Rev Clin Immunol 2010; 6:291.</a></li><li><a class="nounderline abstract_t">Gupta K. Deciphering spongiotic dermatitides. Indian J Dermatol Venereol Leprol 2008; 74:523.</a></li></ol></div><div id="topicVersionRevision">Topic 13655 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27185421" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Allergic contact dermatitis: Patient diagnosis and evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27185421" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Allergic contact dermatitis: Patient diagnosis and evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10066966" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Contact dermatitis II. Clinical aspects and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27364956" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19580930" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Management of occupational dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10912378" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17596159" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17596159" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37192467" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Trends in Patch Testing With the Mayo Clinic Standard Series, 2017-2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24268786" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30370565" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevalence of contact allergy in the general population: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21480911" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21963222" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : [Contact sensitization to allergens in the Spanish standard series at Hospital Costa del Sol in Marbella, Spain: a retrospective study (2005-2010)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19470301" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Patch-test results of the North American Contact Dermatitis Group 2005-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21342229" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Metal patch test results from 1990-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21309787" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A retrospective study of patch tests in Chongqing, China from 2004 to 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21226715" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Fluctuations in the prevalence of nickel and cobalt allergy in eczema patients patch tested after implementation of the nickel regulation in Denmark.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19659962" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20826990" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pediatric contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21851361" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Contact allergy and allergic contact dermatitis in children - a review of current data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20812765" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Contact dermatitis in older adults: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2383986" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The frequency of contact allergy in atopic patients with dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10208505" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19397618" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18279174" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22283138" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Contact sensitization to common haptens is associated with atopic dermatitis: new insight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23583066" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33781959" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28392290" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28392290" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28392290" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20566902" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20566902" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12010340" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Atopic dermatitis is associated with a decrement in health-related quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11422262" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Occupational contact dermatitis has an appreciable impact on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11422262" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Occupational contact dermatitis has an appreciable impact on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9048524" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11899139" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Guidelines for care of contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20672788" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Diagnosis and management of contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15186368" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Clues to an accurate diagnosis of contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20402391" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Diagnostic approach in allergic and irritant contact dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19052433" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Deciphering spongiotic dermatitides.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
